Purpose: Although it is widely used in clinical practice, the mechanisms of action of 2,6-di-isopropylphenol (propofol) are not completely understood. We examined the electrophysiologic effects of propofol on an in vitro model of epileptic activity obtained from a slice preparation.
recorded from cortical neurons. Interestingly, relatively low concentrations of propofol [half-maximal inhibitory concentration (IC 50 ), 3.9 µM) consistently inhibited the "persistent" fraction of Na + currents, whereas even high doses (≤300 µM) had negligible effects on the "fast" component of Na + currents. HVA Ca 2+ currents were significantly reduced by propofol, and the pharmacologic analysis of this effect showed that propofol selectively reduced L-type HVA Ca 2+ currents, without affecting N or P/Q-type channels.
Conclusions: These results suggest that propofol modulates neuronal excitability by selectively suppressing persistent Na + currents and L-type HVA Ca 2+ conductances in cortical neurons. These effects might cooperate with the opening of GABA-Agated chloride channels, to achieve depression of cortical activity during both anesthesia and status epilepticus. Key Words: Cortex-Antiepileptic drugs-Paroxysmal depolarizing shift-HVA calcium current-Persistent sodium current.
Growing experimental evidence suggests that antiepileptic drugs (AEDs) and anesthetics may share common mechanisms of action (1, 2) . Overall, modulation of neuronal activity by both these classes of drugs results from depression of excitatory transmission and enhancement of inhibitory neurotransmission. Indeed, prolongation of γ -aminobutyric acid (GABA)-A receptor function at GABAergic synapses is thought to be a crucial component of the mechanism of action of many anesthetic drugs, as well as of AEDs. Moreover, the molecular targets for many of the drugs belonging to both categories include the modulation of membrane ion channel function. In particular, compelling evidence has demonstrated that sodium (Na + ) current inhibition plays a primary role in the mechanism of action both of many AEDs and of anesthetic agents (3) (4) (5) (6) (7) . More recently, much interest has been focused on the persistent fraction of Na + current (INa + p), as several AEDs have been shown selectively to modulate this current (8) (9) (10) (11) . In addition, high-voltage-activated (HVA) calcium (Ca 2+ ) currents are thought to represent a primary source of intracellular Ca 2+ during epileptiform activity (12) (13) (14) , being involved in both seizure generation and propagation. Similar to Na + currents, HVA Ca 2+ conductances have been shown to be an important target of some anesthetic drugs (6, 7) . A significant overlap also exists in the clinical effects, because many anesthetic drugs possess antiepileptic activity (15) , whereas common AEDs have sedative actions (7) .
Propofol, an intravenous anesthetic, is structurally not related to other anesthetic drugs. Its extensive clinical use has been justified by the early onset and rapid clearance of the effect, and, conversely, by the lack of significant side effects (16) . More recently, propofol has been reported as a successful treatment for refractory status epilepticus (17, 18) . Several cellular mechanisms of action have been proposed for propofol. Electrophysiologic studies demonstrated that propofol activates both phasic and tonic GABA-A receptor-dependent conductances (19) (20) (21) . The enhancement of GABA-A-receptor transmission probably accounts for a large portion of its therapeutic efficacy. In addition, the modulation exerted by propofol on neuronal intrinsic excitability has been shown to depend, at least to some extent, on an inhibitory action on Na + , Ca 2+ , potassium channels (2, 22) . To what extent each of these effects contributes to the efficacy of propofol still remains to be determined. This may be partially due to differences in laboratory investigations, but a crucial determinant is represented by the distinct region-specific and cell-typespecific assembly both of ion-channel and transmitterreceptor subunits. Previous studies have shown that neurons in layer V are necessary for the organization of cortical synchronization; consistently, more recently it has been shown that layer V neurons play a central role in generating cortical seizures (12, 23) .
Intracellular recordings from single neurons performed either in pharmacologically induced epileptic foci or in human tissue from epilepsy patients have shown the existence of epileptiform events, consisting of rhythmic membrane depolarizations of large amplitude, known as paroxysmal depolarization shifts (PDSs), generating repetitive, long-lasting bursts of action potentials (24) . These epileptiform events have been definitely considered a reliable cellular correlate of the electrical abnormalities observed during electroencephalographic recordings (13, 25) . Thus we used an intact preparation such as a slice preparation, which ensures that both the circuitry and the native receptor-subunit composition is preserved and physiologically expressed. In this experimental condition, we analyzed the effects of propofol, by means of conventional sharp microelectrode recordings both on intrinsic membrane properties and on pharmacologically induced PDSs in pyramidal neurons from cortical slices. In addition, whole-cell patch-clamp recordings from acutely isolated pyramidal cells were performed to integrate and identify the molecular target of the actions of propofol.
METHODS

Neocortical slice preparation
Slices were prepared from Wistar rats, 3-4 weeks of age, as described previously (4, 14, 26, 27) , in accordance with European Communities Council Directive (86/609/EEC). Rats were killed under ether anesthesia by cervical dislocation; the brain was rapidly removed, and coronal slices (200 µm thick) from frontal cortex were cut from tissue blocks with a vibratome, in an ice-cold (0
• C) Krebs' solution (see composition later). Then a single slice was placed into a recording chamber mounted on the stage of an upright microscope (Olympus BX50WI), equipped with a ×60 water-immersion objective (LUMPlan FI; Olympus) and submerged in a continuously flowing Krebs' solution gassed with 95% O 2 /5% CO 2 . In the chamber, temperature was maintained at 32
• C to 33
• C, and flow rate was 2.5-3.0 ml/min. The composition of the Krebs' solution was (in mM): 126 NaCl, 2. 
Electrophysiology from brain slices
Intracellular recordings from pyramidal cells were obtained from layer V of the frontal cortex, visualized on the surface of the slice by using a differential interference contrast (DIC, Nomarski) optical system combined with an infrared (IR) filter, a monochrome CCD camera (COHU 4912, Cohu, Inc., San Diego, CA, U.S.A.), displayed on a PC monitor. Sharp microelectrodes were filled with a 2 M KCl solution. However, to avoid interference by chloride ions, most of the experiments were performed with a 2 M K-acetate solution in the recording pipette, yielding a resistance of ∼45-55 MOhms. An Axoclamp 2B amplifier was used for conventional microelectrode recordings from brain slices. Traces were displayed on an oscilloscope (Gould Classic 6000), stored both on a highgain chart recorder (Gould RS 3400) and on AxoScope 9.0 (Axon Instruments Union City, CA, U.S.A.) running on a PC. Off-line analysis was performed with pClamp 9 (Clampfit; Axon Instruments). The drugs were dissolved to the final concentration in the saline and bath-applied after a three-way tap had been turned on. Values given in the text and in the figures are expressed as percentage of control and represent the mean ± SEM of changes in the respective cell populations. Student's t test (for paired and unpaired observations) was used to compare the means.
Preparation of acutely dissociated neurons
Slices from frontal cortex were incubated in Hepesbuffered Hank's balanced salt solution (HBSS), bubbled with pure oxygen. Temperature was kept at 35
• C. Then deep cortical layers were dissected from a neocortical slice and incubated in HBSS medium containing 0.5 mg/ml protease XIV. After 30 min, the tissue was repeatedly washed in HBSS and mechanically dissociated by triturating with a series of progressively smaller fire-polished Pasteur pipettes. The resultant cell suspension was then placed in a Petri dish positioned on the stage of an inverted microscope (Nikon Diaphot; Japan). Healthy cells were allowed to settle for ∼10 min. Only presumed pyramidal neurons were chosen for recordings.
Whole-cell patch-clamp recordings
Pyramidal neurons were identified by their peculiar shape and by the typical apical process spared by the enzymatic dissociation (Fig. 4A) . Patch-clamp recordings in the whole-cell configuration were performed by using fire-polished pipettes (WPI PG52165-4) pulled on a Sutter Flaming-Brown micropipette puller (Sutter Instruments, Novato, CA, U.S.A.). Pipette resistance ranged between 6 and 9 MOhms. Extracellular and dialyzing solutions were prepared to separate Na + and Ca 2+ currents effectively. When either the fast (f ) or the persistent (p) fractions of Na + currents (INa + ) were investigated, cortical neurons were dialyzed with an internal solution containing Conversely, when HVA Ca 2+ currents were examined, the composition of the internal solution was (in mM): Nmethyl-D-glucamine 185, HEPES 40, EGTA 11, MgCl 2 4, and, finally added to the daily-arranged working solution, phosphocreatine 20, ATP 2-3, GTP 0-0.2, and leupeptin 0.2; the osmolarity was 275-280 mOsm/L. After obtaining the cell access, the neuron was usually bathed in a medium composed of (in mM): TEA-Cl 165, HEPES 10, CsCl 5, and BaCl 2 5 as the charge carrier; pH was adjusted to 7.35, and the osmolarity, to ∼300 mOsm/L. Recordings were made with an Axopatch 1D (Axon Instruments, U.S.A.) at room temperature. Series resistance compensation was routinely used (70-80%). Data were low-pass filtered (corner frequency, 5 KHz). For data acquisition and analysis, pClamp 8 running on PC was used. Barium currents were studied with both voltage steps and ramps (0.3-0.6 mV/ms). Control and drug solutions were applied with a linear array of six, gravity-fed capillaries positioned within 500-600 µm of the patched neuron. The pH of the solutions was checked before perfusion.
Data analysis was performed off-line by using Microcal Origin and Graphpad Prism softwares running on PC. Values given in the text and in the figures are mean ± SEM of changes in the respective cell populations. The evaluation of statistical difference was performed with two-way analysis of variance (ANOVA) test.
Drug source and handling
Nimodipine, ω-conotoxin GVIA, ω-conotoxin MVIIC, and ω-agatoxin IVA were from Alomone Labs (Israel). Lamotrigine (LTG) was kindly provided by Glaxo-SmithKline (U.K.). Propofol and all other compounds were purchased from Sigma (Italy).
RESULTS
Characterization of the neurons recorded from slices
Conventional electrophysiological recordings in the current-clamp mode were performed from 57 pyramidal neurons from layer V of the frontal neocortex, visually identified by means of a standard IR-DIC system on the slice surface (Fig. 1A) . Layer borders were assessed by the visualization of a thin layer of large pyramidal neurons, to determine layer V, and by the distance from the pial surface of the slice. Electrophysiologic properties of cortical neurons have been described in detail previously (28, 29) . Distinct neuronal subtypes can be recognized according to their electrical behavior (30) (31) (32) (33) (34) . The recorded neurons had a mean resting membrane potential (RMP) of −71 ± 2 mV. The injection of hyperpolarizing current in the recorded cell evoked a typical hyperpolarization-activated inward current, or I h (Fig. 1B) . In the present work, to render homogeneous the neuronal population, we chose to include only neurons that, on depolarizing current pulses, evoked a sustained action-potential discharge. Cells with an RMP more negative than -65 mV and action potentials Injection of a depolarizing current pulse (0.9 nA, 1 s) evoked a sustained action-potential discharge in a pyramidal neuron (a) (resting membrane potential, RMP, −70 mV). Bathapplication of a low dose of propofol (3 µM) abolished the firing activity (b). A significant decrease in the input resistance of the recorded cell, measured by means of hyperpolarizing current steps (0.8 nA, 400 ms) was observed in propofol (inset). B: In another recording, performed in the presence of bicuculline (BIC; 30 µM) and with K-acetate in the recording microelectrode, propofol (100 µM) was unable to affect either the current-induced firing activity (0.9 nA, 1 s) or the input resistance of the recorded neuron (b, inset). Note that the top of spikes has been truncated. that overshot 0 mV were considered for statistical analysis.
Lack of effect of propofol on action-potential discharge
When tested on repetitive action-potential discharge induced by prolonged depolarizing current pulses (Fig. 2Aa) , bath application of very low doses of propofol (3 µM, 10-20 min) suppressed the firing activity of the recorded neurons ( Fig. 2Ab ; n = 5; p < 0.001). This effect was coupled with a significant decrease in input resistance ( Fig. 2A, inset) . Previous electrophysiologic studies demonstrated that propofol strongly activates the GABA-A receptor-chloride complex in a variety of in vitro preparations. Therefore to rule out the possibility that the effect observed on firing activity was determined by a shunt in neuronal membrane resistance caused by GABA-A-receptor activation, we performed a set of experiments with K-acetate in the recording electrode. However, in such experimental condition, we still observed a suppression of the firing activity by propofol, although less evident (not shown; n = 4). Thus the remaining part of the analysis was performed in the presence of the GABA-A-receptor antagonist bicuculline in the perfusing solution (30 µM) and with K-acetate in the recording electrode (Fig. 2B) . Effectively, in these conditions, even higher doses of propofol (10-100 µM) failed to affect Na + -dependent action-potential discharge ( Fig. 2Bb ; n = 11; p > 0.05), suggesting that the abrupt cessation of firing discharge observed in the former group of experiments was due to a membrane shunt secondary to the opening of GABA-A-dependent chloride channels (35) . Accordingly, in the presence of bicuculline, membrane resistance was unchanged, as measured at the steady state of hyperpolarizing current steps (Fig. 2B, inset) .
Propofol effect on epileptiform activity
The apparent lack of effect of propofol on Na + -dependent firing activity prompted us to search for an effect in another experimental condition (i.e., the pharmacologic induction of epileptiform events). Incubation of the slices in a magnesium-free solution containing 4-aminopyridine (4-AP, 500 µM) and bicuculline (BIC, 30 µM) resulted in the induction of spontaneous epileptiform events, named PDSs. This experimental condition allows removal of the magnesium-dependent block FIG. 3 . Propofol inhibits cortical epileptiform activity. A: Perfusion of the slice with a solution containing low-magnesium, 30 µM bicuculline (BIC) and 0.5 mM 4-aminopyridine (4-AP; 15-20 min) caused the appearance of epileptiform activity in pyramidal neurons, characterized by periodic, long-lasting bursts and by occasional interictal activity. Each burst was followed by a pronounced after-hyperpolarization. Resting membrane potential (RMP), −71 mV. B: Incubation of the slice with 100 µM propofol (10-20 min) caused a marked reduction of the burst duration. Duration was measured from the onset of firing activity to the half-decay time of repolarization. The number of spikes per burst was reduced. The amplitude of the after-hyperpolarization was largely reduced as well. Both duration and number of spikes of paroxysmal depolarization shifts (PDSs) were partially restored to control conditions after a long washout (∼40 min) of propofol. RMP, −68 mV. C: Dose-response curve for the inhibitory effect of propofol on epileptiform events. Each point represents the mean of at least four independent observations. of NMDA glutamate receptors, blocking of potassium channels, and antagonizing of GABA-A receptors, respectively. Twenty minutes after the onset of bath-application of the slice with this solution, spontaneous PDSs were recorded ( Fig. 3A and B ; n = 37), consisting of large shifts of membrane potential in the depolarizing direction (12 ± 1.2 mV amplitude). PDSs had a mean frequency close to 0.1 Hz and triggered long-lasting (1.4 ± 0.2 s) bursts of action potentials, followed by a marked afterhyperpolarization (AHP). Expectedly, tetrodotoxin (TTX, 1 µM) fully suppressed the PDSs (n = 3, not shown). Likewise, PDSs were fully blocked by 100-200 µM cadmium, demonstrating the close dependence of PDS on Ca 2+ influx (n = 4, not shown).
Perfusion of the slices with propofol (3-300 µM) significantly decreased the duration of PDSs (Fig. 3B) . Duration was measured from the onset of spike discharge to the half-decay time of the repolarizing phase. No significant change of the PDS frequency rate was observed (not shown). These effects were dose dependent, with a maximal inhibition obtained at 100 µM ( Fig. 3C ; n = 24; p < 0.001), and with a half-maximal effective dose (EC 50 ) for the inhibitory effect of 23.54 µM. The effect of propofol was paralleled by a decreased number of action potentials inscribed on each burst (Fig. 3B) . In 100 µM propofol, the number of spikes per burst was decreased by 45 ± 7.1% (p < 0.01). Finally, the pronounced AHP after each PDS was largely reduced by bath-applied propofol (Fig. 3B) . A long drug washout was necessary (20-40 min) to allow a partial recovery of PDS duration.
Selective inhibitory action of propofol on INa
+ p Fifty-five pyramidal neurons were acutely isolated from layer V of frontal cortex. The typical pyramidal shape with one main apical dendrite allowed their unequivocal identification (Fig. 4A) . Both fast inactivating (INa + f ) and slowly inactivating/persistent INa + (INa + p) could be evoked in these neurons (Fig. 4B) . Total INa + was evoked by means of depolarizing ramp potentials (from -70 to +30 mV); both current fractions were sensitive to TTX (100 nM, Fig. 4B ). All the recorded cells exhibited a prominent INa + p, which was evoked by ramping membrane voltage from -70 mV to +15 mV (25 mV/s), slowly enough to avoid transient Na + channel opening and consistently capable of evoking the small, persistent, TTX-sensitive INa + p (Fig. 5A ). In agreement with previous findings in cortical neurons (36, 37) , INa + p begins to activate between -65 and −55 mV, with a peak around −35/−40 mV (not shown). Propofol was bath-applied in a solution containing both BIC (30 µM) and 5-nitro 2-(3-phenylpropylamine) benzoic acid (NPPB; 10 µM), a mixed blocker of volume-activated and Ca 2+ -activated chloride channels. In this experimental condition, low concentrations of propofol were able reversibly to suppress the peak amplitude of INa + p (Fig. 5A ). This inhibition was dose dependent, with an IC 50 of 3.9 µM (Fig. 5B) , a maximal inhibition at 30 µM, and a calculated Hill coefficient of 1.3 ± 0.3. The effects of propofol were then tested on INa + f evoked by current steps ranging from the holding potential (−70 mV) to -20 mV (Fig. 5C ). This set of experiments was performed in a low-Na + -containing solution (see Methods for details), added with BIC and NPPB (30 and 10 µM, respectively). Propofol, at all the doses tested (0.1-300 µM) failed to affect INa + f ( Fig. 5C and D; n = 15; p > 0.05). No change in current activation was observed during the control experiments, in which the neurons were perfused with dimethylsulfoxide (DMSO) at the same concentration as that used to dissolve propofol (not shown; n = 3).
Comparative study with valproic acid
To compare the effects of propofol with a wellestablished AED, another set of experiments was performed with valproic acid (VPA). This drug is known selectively to affect the persistent fraction of INa + (9). Indeed, the addition of VPA (100 µM) to the perfusing solution had no effect on INa + f amplitude, whereas it significantly reduced INa + p ( Fig. 6A and B; n = 6; p < 0.01). The effect of VPA on PDS was then analyzed. VPA (200 µM, 30 min) was able to reduce by 56.8 ± 1.8% the number of action potentials inscribed on each PDS ( Fig. 6C ; n = 5; p < 0.01) without significantly affecting the duration of PDS ( Fig. 6C ; 5.5 ± 4.3% inhibition; p > 0.05).
Blockade of L-type HVA Ca
2+ channels With barium as the charge carrier, HVA Ca 2+ currents were isolated from 38 pyramidal cells. From a negative holding potential (−90 mV), HVA currents were activated by standard test-pulses (from −10 to +10 mV) or ramp activation protocol ranging from -70 to + 40 mV. All the experiments were performed in the presence of BIC (30 µM) and NPPB (10 µM) in the bathing solution. Propofol (1-300 µM), dose dependently reduced barium currents in all the recorded neurons (Fig. 7) . The maximal inhibition was obtained at a concentration of 100 µM ( Fig. 7C ; 26 ± 3.8%; n = 12; p < 0.001). Determined IC 50 for the inhibition by propofol was 23.1 ± 0.6 µM. As shown in Fig. 7A and B, the blockade of HVA currents reversed on washout of propofol, independent of the dose tested. A set of experiments was then performed to discriminate the HVA Ca 2+ channel subtype involved in this inhibitory action of propofol. The dihydropyridine blocker nimodipine selectively blocks L-type channels in a concentration range between 5 and 50 µM. Bath-application of 5 µM nimodipine reduced the total Ca 2+ current activated by step pulses by 23.1 ± 4% ( Fig. 8A and B ; n = 8; p < 0.001). Interestingly, in the presence of nimodipine, the inhibition of saturating doses of propofol (100 µM) was occluded ( Fig. 8A and B ; n = 8; p > 0.05), suggesting that dihydropyridine-sensitive currents play a prominent role in the inhibitory action of propofol on cortical neurons. Conversely, N-, P-, and Q-type HVA currents do not appear to be preferential targets of propofol. Perfusion with 1 µM ω-conotoxin GVIA, a peptide known to selectively block N-type HVA channels reduced, per se, the peak amplitude currents by 33.3 ± 3.4% ( Fig. 8C and D; n = 6; p < 0.005). However, in the presence of 1 µM ω-conotoxin GVIA, bath-applied propofol (100 µM) was still effective, resulting in a cumulative inhibitory effect ( Fig. 8C and D; 54.2 ± 3.2%; n = 5; p < 0.001). Then we analyzed the possible involvement of P-and Q-type HVA channels. Application of the selective blocker of P-type channels, ω-agatoxin IVA (20 nM), caused a reduction of the total Ca 2+ current of 17.1 ± 4% ( Fig. 8E ; n = 5; p < 0.001). Yet the inhibition caused by propofol was not antagonized (Fig. 8E; 49.1 ± 2%; n = 5; p < 0.005). Likewise, the blockade of Q-type HVA current fraction by ω-conotoxin MVIIC (100 nM; Fig. 8F ; 16.8 ± 3.2%; n = 9; p < 0.001) did not modify the inhibition by propofol (Fig. 8F ; 41.5 ± 2.3%; n = 8; p < 0.005). Finally, in four pyramidal neurons, the effect of DMSO was tested, at concentrations used to dissolve propofol. A vehicle-induced reduction of peak HVA current amplitude was observed (<10%), which was subtracted from all the data presented.
DISCUSSION
Current theories suggest common sites of action for anesthetics and antiepileptic drugs. Despite this evidence, the identification of the molecular targets of these drugs remains, in some aspects, elusive. In the present work, we used conventional recordings to show that propofol effectively reduces both duration and spiking activity of epileptiform events in cortical pyramidal neurons from a slice preparation. The data obtained from whole-cell recordings suggest that such an inhibitory effect might be at least partially ascribed to the selective modulation of both the INa + p fraction and L-type HVA Ca 2+ currents.
The hallmark of the epileptiform activity is represented by repetitive, persistent depolarization of the neuronal voltage lasting seconds to minutes (24, 25) . Spontaneous shifts in membrane potential, PDSs, have been shown to occur both in pharmacologically induced epileptic foci and in human tissue from epilepsy patients undergoing surgery. These events have long been considered the cellular correlate of epileptic activity (25) . We found that propofol decreases both the number of action potentials per burst and the duration of these events. Interestingly, PDSs were hypothesized to be sustained by INa + p (8, 38) . This current fraction is thought to play a central role both in governing the excitability of cortical pyramidal neurons and in the generation of epileptiform activity (8, 36, 37) . Most of the studies of anticonvulsant actions on Na + currents to date have examined the effects of the drugs on the peak Na + current (39, 40) . However, if a INa + p is crucial in maintaining ictal depolarization, it may be the most relevant portion of the Na + current to study. To our knowledge, the present data provide the first experimental evidence of an inhibitory action of an anesthetic drug on INa + p. Notably, this inhibition was obtained at relatively low concentrations of propofol, which confers a certain selectivity to its action. Indeed, it is commonly accepted that low concentrations may selectively target the INa + p fraction of the total INa + , whereas the (8) (9) (10) 41) . In line with such experimental evidence, our comparative analysis confirmed that VPA selectively targets INa + p, with no effect on INa + f . Moreover, in line with these observations is also the lack of effect of propofol on current-induced action-potential discharge observed in the present study and recently reported in hippocampal interneurons (21) . Both in our study and in the latter work, the suppression of action-potential firing was fully prevented by blocking GABA-A receptoroperated chloride conductances. The blockade of INa + p might also account for the inhibitory effect on the spiking activity inscribed on each PDS, because this current fraction is thought to sustain bursting activity in pyramidal cortical neurons (36) . Thus its blockade by propofol might contribute to the overall reduced excitability.
Few electrophysiological studies have analyzed the role of INa + currents in the mechanism of action of propofol. Previously, INa + currents were examined in synaptosomal preparations, with toxin-treated activated Na + channels (42) . Recently, propofol, tested on IIa Na + channel α subunits transfected in Chinese hamster ovary cells, was found to suppress total Na + currents both by causing a hyperpolarizing shift of steady-state inactivation and by a use-dependent block of the channel (22) . These findings are in apparent contrast with our data supporting a selective action of propofol on INa + p rather than a generalized block of total INa + . Some methodologic differences might account for this apparent discrepancy, such as the cell type used: we recorded pyramidal neurons whose native channel subunit composition is preserved. Furthermore, the persistent fraction of INa + was not investigated in the previous work.
Compelling evidence supports a central role of Ca 2+ channels in epileptogenesis. The prolonged membrane depolarization during PDS causes a sustained activation of HVA currents, allowing a significant intracellular Ca 2+ influx (12, 14) . Moreover, an anomalous assembly of HVA Ca 2+ channel subunits, as has been shown in a variety of mutant rodent models, such as the epileptic-lethargic mouse (43), appears of critical importance in the mechanisms underlying epilepsy. Hence a central mechanism by which AEDs modulate intrinsic neuronal excitability is represented by the inhibition of Ca 2+ currents. Different AEDs have been shown to modulate HVA currents, such as levetiracetam (14) , felbamate (FBM), and gabapentin (GBP). Among these, FBM and GBP have been found to interact selectively with L-type HVA channels (44, 45) . Our results suggest that in cortical neurons, propofol selectively targets dihydropyridine-sensitive Ca 2+ currents, which represent nearly 25% of the whole Ca 2+ conductance. Indeed, the inhibitory action on Ca 2+ currents by
Selective blockade of L-type high-voltage activated (HVA) Ca 2+ currents by propofol. A: Barium currents were activated by step pulses ranging from -10 mV to +10 mV. The selective L-type Ca 2+ channel blocker nimodipine (nimo, 5 µM) largely suppressed the total Ca 2+ current. In the presence of nimodipine, the inhibitory effect of saturating concentrations of propofol was occluded. B: Cumulative plot showing the occlusion by nimodipine on the inhibitory action of propofol. C: One µM ω-conotoxin GVIA (ω-ctx) significantly reduced the total Ca 2+ current. However, with addition of propofol to the solution, an additive effect was obtained. D: The plot shows how the inhibition produced by 100 µM propofol was further enhanced by ω-conotoxin GVIA. E, F: The inhibitory effect of saturating doses of propofol was not occluded either by 20 nM ω-agatoxin IVA or by 100 nM ω-conotoxin MVIIC, selective blockers of P-type and Q-type HVA currents, respectively. The plots shown in B, D, E, and F represent the mean ± SEM of at least six independent recordings for each HVA antagonist.
saturating concentrations of propofol was selectively occluded by nimodipine, whereas perfusion with other channel subtype blockers resulted in an additive inhibition. These results are in accordance with previous observations obtained in spinal and supraoptic neurons (46, 47) . The modulatory action on L-type channels might well explain the decrease in PDS duration reported in the present work. Indeed, PDSs are plateau potentials, with a prominent component mediated by activation of L-type Ca 2+ conductances (46) . Similarly, the blockade of L-type HVA channels might well account for the inhibition of AHP after each PDS, because AHP is mediated largely by Ca 2+ -activated potassium currents (48, 49) . At present, a possible effect on different types of potassium currents (50) cannot be ruled out, and future work is required to address this issue.
Clinical implications
The convergence of the EC 50 values for the inhibitory effects of propofol both on PDS duration and HVA channels indeed suggests that Ca 2+ current blockade might represent a primary mechanism for the antiepileptic action of this drug. However, the issue of clinically relevant concentrations for intravenous anesthetics is complex, mainly because of the difficulty of establishing steady-state free concentrations of anesthetic drugs in the brain (6, 51) . Hence caution should be paid when determining a direct correlation between propofol concentrations tested in vitro and clinically effective plasma levels. Indeed, several pharmacokinetic parameters may account for such discrepancy: this may be particularly relevant with respect to propofol, a highly lipophilic drug, with a significant binding to plasma proteins (52) . In our study, we found that propofol selectively blocked INa + p with an IC 50 of ∼4 µM, which is a rather low concentration, in accordance with previously calculated therapeutic plasma levels. Moreover, propofol has been reported to reduce peak Na + currents in Chinese hamster ovary cells transfected with rat brain IIa Na + channels with an IC 50 of 10 µM (22) . An in vivo study performed in rats reported that clinically relevant doses of propofol during anesthesia are >10 µM (53) .
Thus it may be conceivable to assume that low drug concentrations, such as those found to inhibit INa + p, may possibly participate to its antiepileptic efficacy observed in the treatment of refractory status epilepticus (17, 18) .
